Advancing Personalized Medicine Through FDM 3D Printing: Ketoprofen Tablets with Customizable Drug Release Profiles and In Silico Simulation
Pharmaceutics · 19.11.2025 · 17 (11) · 1495
DOI: 10.3390/pharmaceutics17111495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 19.11.2025. Verfasst von Haya Khader Ahmad Yasin und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang 11800, Malaysia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajman University, Ajman University Internal Research.
Abstract (Originalsprache)
Background/Objectives: Fused deposition modeling (FDM) three-dimensional (3D) printing represents an emerging manufacturing platform for personalized oral dosage forms. Its success relies on developing robust drug-loaded filaments with consistent mechanical, thermal, and dissolution properties. This work aims to (i) develop and characterize ketoprofen-loaded filaments using hot-melt extrusion (HME) and (ii) utilize them to fabricate both immediate-release (IR) and sustained-release (SR) tablets via FDM 3D printing.
Methods
Filaments were prepared using Kollicoat® IR and hydroxypropyl methylcellulose (HPMC, 2600–5600 cP) as functional polymers. Sorbitol and sodium lauryl sulfate (SLS) were incorporated as plasticizer and surfactant, respectively. Filaments were evaluated for quality attributes, drug content, tensile strength, and physicochemical and surface characteristics using Scanning Electron Microscopy (SEM), Attenuated Total Reflection Fourier-transform infrared (ATR-FTIR), X-ray Diffraction (XRD), Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA). Optimized filaments were fed into an FDM 3D printer to fabricate ketoprofen tablets with varied geometries, shell numbers, and infill densities. Tablets were subjected to USP tests (weight variation, friability, hardness, disintegration, assay, content uniformity), dissolution profiling, and release kinetics modeling. Comparative dissolution studies with market Profenid® and Bi-Profenid® tablets were conducted. GastroPlus® simulations were used for in vitro–in silico correlation.
Results
Among the tested formulations, Kollicoat® IR-based filaments with sorbitol and SLS (F6) demonstrated superior printability, characterized by consistent feeding, stable extrusion, and reliable formation of uniform structures for immediate-release applications. In contrast, HPMC-based filaments with sorbitol (F13) offered the most robust performance for SR formulations. Both exhibited uniform diameter, drug loading, and mechanical strength. IR tablets achieved >80% release within 30 min, while SR tablets prolonged release up to 12 h, following Higuchi and Korsmeyer–Peppas kinetics. All quality attributes complied with USP limits. Market products showed comparable dissolution, validating the approach. GastroPlus® simulations predicted pharmacokinetic profiles consistent with reported data, supporting IVIVC.
Conclusions
This integrated workflow establishes a robust strategy for producing IR and SR ketoprofen tablets from a single FDM platform. The results highlight the feasibility of point-of-care, personalized medicine using 3D printing technologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang 11800, Malaysia.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
ORCID-Profile: Haya Khader Ahmad Yasin, Moawia M Al-Tabakha, Siok Yee Chan
Förderung
- Ajman University
- Ajman University Internal Research
Zitieren
APA
Yasin, H. K. A., Al-Tabakha, M. M., & Chan, S. Y. (2025). Advancing Personalized Medicine Through FDM 3D Printing: Ketoprofen Tablets with Customizable Drug Release Profiles and In Silico Simulation. Pharmaceutics, 17(11), 1495. https://doi.org/10.3390/pharmaceutics17111495
Vancouver
Yasin HKA, Al-Tabakha MM, Chan SY. Advancing Personalized Medicine Through FDM 3D Printing: Ketoprofen Tablets with Customizable Drug Release Profiles and In Silico Simulation. Pharmaceutics. 2025;17(11):1495. doi:10.3390/pharmaceutics17111495
BibTeX
@article{Yasin2025,
author = {Yasin, Haya Khader Ahmad and Al-Tabakha, Moawia M and Chan, Siok Yee},
title = {Advancing Personalized Medicine Through FDM 3D Printing: Ketoprofen Tablets with Customizable Drug Release Profiles and In Silico Simulation},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {11},
pages = {1495},
doi = {10.3390/pharmaceutics17111495}
}
EUVIMED